The antiapoptotic activity of melatonin in neurodegenerative diseases

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Neurodegenerative diseases are characterized by neuronal cell death.
• Apoptotic pathways (intrinsic and extrinsic) are key drivers of neurodegeneration.
• Melatonin is known to have neuroprotective effects, but mechanisms are unclear.

Purpose of the Study:

• To review the role of melatonin in inhibiting intrinsic apoptotic pathways in neurodegenerative diseases.
• To discuss the activation of survival signal pathways by melatonin in these conditions.

Main Methods:

• Literature review of studies on melatonin and neurodegeneration.
• Analysis of research on apoptotic and survival pathways.
• Synthesis of findings across various neurodegenerative disease models.

Main Results:

• Melatonin inhibits the intrinsic apoptotic pathway in models of stroke, Alzheimer's, Parkinson's, Huntington's, and ALS.
• Melatonin activates anti-apoptotic and pro-survival signaling cascades.
• Evidence suggests melatonin's multifaceted role in neuroprotection.

Conclusions:

• Melatonin demonstrates significant neuroprotective potential by modulating apoptosis and survival pathways.
• Understanding these mechanisms can inform therapeutic strategies for neurodegenerative diseases.
• Further research is warranted to fully elucidate melatonin's therapeutic applications.